Significance of CD103(+) tissue-resident memory T cells for predicting the effectiveness of immune checkpoint inhibitors in esophageal cancer

BACKGROUND: Immune checkpoint inhibitors (ICIs), including nivolumab, have been approved to treat esophageal cancer. However, these remedies are not fit for all patients with esophageal cancer; therefore, a predictive surrogate marker is needed to assess their effectiveness. CD103(+)CD8(+) tumor-inf...

Descripción completa

Detalles Bibliográficos
Autores principales: Natsuki, Seiji, Tanaka, Hiroaki, Nishiyama, Masaki, Deguchi, Sota, Miki, Yuichiro, Yoshii, Mami, Tamura, Tatsuro, Toyokawa, Takahiro, Lee, Shigeru, Maeda, Kiyoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10588150/
https://www.ncbi.nlm.nih.gov/pubmed/37864146
http://dx.doi.org/10.1186/s12885-023-11438-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10588150/
https://www.ncbi.nlm.nih.gov/pubmed/37864146
http://dx.doi.org/10.1186/s12885-023-11438-5

Ejemplares similares